These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 14687809

  • 1. Intragastric pH during continuous infusion with pantoprazole in patients with bleeding peptic ulcer.
    van Rensburg CJ, Hartmann M, Thorpe A, Venter L, Theron I, Lühmann R, Wurst W.
    Am J Gastroenterol; 2003 Dec; 98(12):2635-41. PubMed ID: 14687809
    [Abstract] [Full Text] [Related]

  • 2. Pantoprazole infusion as adjuvant therapy to endoscopic treatment in patients with peptic ulcer bleeding: prospective randomized controlled trial.
    Zargar SA, Javid G, Khan BA, Yattoo GN, Shah AH, Gulzar GM, Sodhi JS, Mujeeb SA, Khan MA, Shah NA, Shafi HM.
    J Gastroenterol Hepatol; 2006 Apr; 21(4):716-21. PubMed ID: 16677158
    [Abstract] [Full Text] [Related]

  • 3. Comparison of p.o. or i.v. proton pump inhibitors on 72-h intragastric pH in bleeding peptic ulcer.
    Javid G, Zargar SA, U-Saif R, Khan BA, Yatoo GN, Shah AH, Gulzar GM, Sodhi JS, Khan MA.
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1236-43. PubMed ID: 19682194
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Intravenous pantoprazole versus ranitidine for prevention of rebleeding after endoscopic hemostasis of bleeding peptic ulcers.
    Hsu PI, Lo GH, Lo CC, Lin CK, Chan HH, Wu CJ, Shie CB, Tsai PM, Wu DC, Wang WM, Lai KH.
    World J Gastroenterol; 2004 Dec 15; 10(24):3666-9. PubMed ID: 15534928
    [Abstract] [Full Text] [Related]

  • 9. Randomized controlled trial of high dose bolus versus continuous intravenous infusion pantoprazole as an adjunct therapy to therapeutic endoscopy in massive bleeding peptic ulcer.
    Yamada S, Wongwanakul P.
    J Med Assoc Thai; 2012 Mar 15; 95(3):349-57. PubMed ID: 22550833
    [Abstract] [Full Text] [Related]

  • 10. Intragastric pH and serum gastrin during administration of different doses of pantoprazole in healthy subjects.
    Koop H, Kuly S, Flüg M, Eissele R, Mönnikes H, Rose K, Lühmann R, Schneider A, Fischer R, Arnold R.
    Eur J Gastroenterol Hepatol; 1996 Sep 15; 8(9):915-8. PubMed ID: 8889461
    [Abstract] [Full Text] [Related]

  • 11. A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy.
    Lin HJ, Lo WC, Lee FY, Perng CL, Tseng GY.
    Arch Intern Med; 1998 Jan 12; 158(1):54-8. PubMed ID: 9437379
    [Abstract] [Full Text] [Related]

  • 12. Will Helicobacter pylori affect short-term rebleeding rate in peptic ulcer bleeding patients after successful endoscopic therapy?
    Lin HJ, Tseng GY, Hsieh YH, Perng CL, Lee FY, Chang FY, Lee SD.
    Am J Gastroenterol; 1999 Nov 12; 94(11):3184-8. PubMed ID: 10566712
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Optimizing the intragastric pH as a supportive therapy in upper GI bleeding.
    Brunner G, Luna P, Hartmann M, Wurst W.
    Yale J Biol Med; 1996 Nov 12; 69(3):225-31. PubMed ID: 9165691
    [Abstract] [Full Text] [Related]

  • 17. Esomeprazole 40 mg i.v. provides faster and more effective intragastric acid control than pantoprazole 40 mg i.v.: results of a randomized study.
    Wilder-Smith CH, Röhss K, Bondarov P, Hallerbäck B, Svedberg LE, Ahlbom H.
    Aliment Pharmacol Ther; 2004 Nov 15; 20(10):1099-104. PubMed ID: 15569112
    [Abstract] [Full Text] [Related]

  • 18. Intragastric acidity during treatment with esomeprazole 40 mg twice daily or pantoprazole 40 mg twice daily--a randomized, two-way crossover study.
    Miehlke S, Madisch A, Kirsch C, Lindner F, Kuhlisch E, Laass M, Knoth H, Morgner A, Labenz J.
    Aliment Pharmacol Ther; 2005 Apr 15; 21(8):963-7. PubMed ID: 15813831
    [Abstract] [Full Text] [Related]

  • 19. Effect of intravenous application of esomeprazole 40 mg versus pantoprazole 40 mg on 24-hour intragastric pH in healthy adults.
    Hartmann D, Eickhoff A, Damian U, Riemann JF, Schilling D.
    Eur J Gastroenterol Hepatol; 2007 Feb 15; 19(2):133-7. PubMed ID: 17272998
    [Abstract] [Full Text] [Related]

  • 20. Oral and intravenous dosage forms of pantoprazole are equivalent in their ability to suppress gastric acid secretion in patients with gastroesophageal reflux disease.
    Metz DC, Pratha V, Martin P, Paul J, Maton PN, Lew E, Pisegna JR.
    Am J Gastroenterol; 2000 Mar 15; 95(3):626-33. PubMed ID: 10710049
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.